h.kimani
TL2 Moderator · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 20 February 2025 · last posted 5d
92 posts, newest first. Showing up to 150.
-
What changed in 2026, by region — does this still hold? Replied, post #25 · Access › International · 23 Jul 2026 · 28 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #88 · Access › Insurance & coverage · 21 Jul 2026 · 5 likes This follows post #85 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Sleep quality changes during weight loss Replied, post #25 · Wellbeing › Sleep · 21 Jul 2026 · 10 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Here for the analytics and not much else Replied, post #35 · Lounge › Introductions · 15 Jul 2026 · 19 likes Lurking first: if you want to introduce yourself after lurking a bit, that is fine. You do not have to introduce yourself before your first technical post either.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #43 · Practice › Interactions · 14 Jul 2026 · 17 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #100 · Evidence › Journal club · 12 Jul 2026 · 0 likes Coming back to post #98, because the follow-up matters more than the original answer. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2026 · 13 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #29 · Sourcing › Independent verification · 8 Jul 2026 · 5 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #121 · Sourcing › Logistics · 2 Jul 2026 · 2 likes This follows post #118 rather than contradicting it. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #67 · Compounds › Oral incretins · 30 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #6 · marked as the solution · Compounds › Repair & healing peptides · 29 Jun 2026 · 9 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #85 · Practice › Administration · 26 Jun 2026 · 7 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Conditions that change the calculus rather than forbidding it Replied, post #25 · Safety › Contraindications · 26 Jun 2026 · 0 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #19 · Evidence › Meta-analyses · 25 Jun 2026 · 30 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Pooling trials with different estimands Replied, post #41 · Evidence › Meta-analyses · 22 Jun 2026 · 32 likes Picking up post #38: that is the part I would want checked first. Publication bias: what did not get published? Small studies with negative results are less likely to…
-
Historical amylin analogues and what happened to them Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2026 · 14 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #37 · Clinical › Special populations · 3 Jun 2026 · 27 likes I read post #35 twice before replying, because I had assumed the opposite. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #44 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 3 likes Worth separating two things that post #40 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #69 · Data & Tools › Datasets · 22 May 2026 · 25 likes Picking up post #66: that is the part I would want checked first. Using data in discussions: datasets are useful as reference points when someone claims something…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #77 · Compounds › Tirzepatide · 22 May 2026 · 7 likes post #76 answers the question as asked. The question underneath it is different. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #23 · Analytics › Home & field testing · 16 May 2026 · 0 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
-
Bioimpedance and hydration: why the number moves Replied, post #45 · Outcomes › Body composition · 15 May 2026 · 1 like Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Started this topic · Analytics › Mass spectrometry · 15 May 2026 · 1 like On the subject in the title: Mass error in ppm: the arithmetic and the caveat — a second dataset Working notes rather than a conclusion. Working through the identity…
-
The best-written scientific paper you have read Replied, post #45 · Lounge › Off topic · 14 May 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
Reading a home test result without over-claiming Replied, post #16 · Analytics › Home & field testing · 18 Apr 2026 · 24 likes Coming back to post #14, because the follow-up matters more than the original answer. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #30 · Analytics › COA interpretation · 10 Apr 2026 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #8 · Compounds › Retatrutide · 19 Mar 2026 · 1 like Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
Second pass at: What to keep a record of at the point of payment Replied, post #19 · Sourcing › Payments · 15 Mar 2026 · 5 likes This follows post #16 rather than contradicting it. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk.…
-
Preservatives: function, testing, and limits — one year on Replied, post #4 · Pharmacology › Formulation chemistry · 12 Mar 2026 · 1 like Amino acid residues and formulation: the specific sequence and composition of a peptide affects what formulation conditions it tolerates. Sequences high in methionine…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #13 · Analytics › HPLC & UHPLC · 28 Feb 2026 · 7 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #12 · Evidence › Trials · 24 Feb 2026 · 17 likes post #11 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
-
Managing an unplanned gap in supply Replied, post #37 · Access › Shortages · 20 Feb 2026 · 0 likes Picking up post #34: that is the part I would want checked first. International supply chains: a shortage in one country does not mean shortage in another. That is why…
-
Journal club: LEADER as the historical anchor Replied, post #36 · Evidence › Journal club · 17 Feb 2026 · 11 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #3 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Temperature indicator cards: worth asking for? Replied, post #2 · Sourcing › Logistics · 30 Jan 2026 · 9 likes Coming back to the opening post, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #66 · Regional › UK & Ireland · 14 Jan 2026 · 1 like Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #68 · Sourcing › Independent verification · 4 Jan 2026 · 14 likes This follows post #65 rather than contradicting it. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #6 · Sourcing › Vendor reports · 1 Jan 2026 · 2 likes Worth separating two things that post #2 runs together. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity.…
-
Tracking a preprint to publication: a worked example Replied, post #148 · Evidence › Preprints · 14 Dec 2025 · 0 likes Coming back to post #146, because the follow-up matters more than the original answer. Preprints for speed: some important preliminary findings are posted as preprints…
-
What pooling buys you and what it destroys Replied, post #79 · Evidence › Meta-analyses · 30 Nov 2025 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Revisiting: Reading order for a first week here, and what to skip until later Replied, post #2 · Start Here › Welcome · 19 Nov 2025 · 1 like On the opening post — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #16 · Practice › Side effects · 15 Nov 2025 · 14 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Managing an unplanned gap in supply — what changed since Replied, post #114 · Access › Shortages · 12 Nov 2025 · 26 likes I read post #112 twice before replying, because I had assumed the opposite. Communication from suppliers: a supplier having supply problems usually communicates them.…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #44 · Compounds › Tirzepatide · 11 Nov 2025 · 4 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #17 · Practice › Storage & stability · 30 Oct 2025 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #59 · Compounds › Tirzepatide · 29 Oct 2025 · 23 likes On post #55 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #29 · Compounds › Semaglutide · 29 Oct 2025 · 2 likes Coming back to post #27, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #27 · Safety › Adverse events · 16 Oct 2025 · 13 likes Picking up post #24: that is the part I would want checked first. How to document: date, exact symptom or event, severity, duration, outcome, any medical attention…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #9 · Safety › Adverse events · 10 Oct 2025 · 2 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
The headache that turns out to be dehydration Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 2 Oct 2025 · 20 likes On post #8 — agreed on the reasoning, with one qualification. Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific.…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #7 · Research Methods › N-of-1 designs · 23 Sep 2025 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #53 · Practice › Dosing & titration · 17 Sep 2025 · 1 like Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
A comparison of home results against a laboratory result on the same vial Replied, post #36 · Analytics › Home & field testing · 13 Sep 2025 · 17 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #50 · Practice › Side effects · 10 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
High-resolution MS on aggregates and what it can see Replied, post #62 · Analytics › Mass spectrometry · 7 Sep 2025 · 25 likes Coming back to post #60, because the follow-up matters more than the original answer. What mass accuracy establishes: the measured mass is consistent with a specific…
-
When to stop reading forums, including this one Replied, post #18 · Wellbeing › Mental health · 24 Aug 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Specification in the result column: why that is a meaningful error Replied, post #32 · Analytics › COA interpretation · 17 Aug 2025 · 0 likes post #31 is right about the mechanism and I think understates the practical bit. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
-
System suitability injections: if they failed, the run did not happen Replied, post #22 · Analytics › HPLC & UHPLC · 12 Aug 2025 · 0 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #10 · Practice › Administration · 5 Aug 2025 · 28 likes post #9 answers the question as asked. The question underneath it is different. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
About the Trials category Replied, post #9 · Evidence › Trials · 19 Jul 2025 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation…
-
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #18 · Sourcing › Payments · 2 Jul 2025 · 0 likes Picking up post #15: that is the part I would want checked first. Escrow services: some third-party services hold payment until the buyer confirms receipt. They add…
-
Substitution between formats during a shortage Replied, post #16 · Access › Shortages · 30 Jun 2025 · 0 likes post #15 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #16 · Sourcing › Vendor reports · 23 Jun 2025 · 0 likes post #15 answers the question as asked. The question underneath it is different. Multiple services on one lot: agreement across two independent laboratories is stronger…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #132 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 28 likes post #131 is right about the mechanism and I think understates the practical bit. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #34 · Nutrition & Training › Protein & intake · 24 May 2025 · 10 likes post #33 is right about the mechanism and I think understates the practical bit. Timing of protein: spreading protein intake across the day, with some at each meal, is…
-
Follow-up: What other technical communities get right that we do not Replied, post #104 · Lounge › Off topic · 20 May 2025 · 0 likes I read post #102 twice before replying, because I had assumed the opposite. Lower-stakes conversation that does not belong in the technical categories. Still civil,…
-
Pages past their review date, listed — does this still hold? Replied, post #13 · Meta › Wiki maintenance · 7 May 2025 · 11 likes On post #9 — agreed on the reasoning, with one qualification. Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
What a 2 ppm match establishes, and what it does not Replied, post #15 · Analytics › Mass spectrometry · 2 May 2025 · 20 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Reading order for a first week here, and what to skip until later Replied, post #111 · Start Here › Welcome · 1 May 2025 · 16 likes Coming back to post #109, because the follow-up matters more than the original answer. The moderation log is public. Every staff action is logged with the rule cited…
-
Telehealth prescribing models in the US Replied, post #89 · Regional › North America · 24 Apr 2025 · 29 likes Coming back to post #87, because the follow-up matters more than the original answer. Regional variation in North America: access differs substantially by US state and…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #25 · Evidence › Journal club · 17 Apr 2025 · 0 likes post #24 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Scheduled maintenance and what will be unavailable Replied, post #110 · Meta › Announcements · 15 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Review cadence: how often is a page actually re-checked? Replied, post #11 · Documentation › Doc review · 7 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #33 · Practice › Reconstitution · 6 Apr 2025 · 32 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Transit times by route, from a logged dataset — the long version Replied, post #77 · Sourcing › Logistics · 2 Apr 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #64 · Wellbeing › Mental health · 20 Mar 2025 · 4 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Charge states for a 4 kDa peptide, worked through Replied, post #142 · Analytics › Mass spectrometry · 18 Mar 2025 · 4 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Reading a chromatogram someone posted without axes Replied, post #12 · Analytics › HPLC & UHPLC · 18 Mar 2025 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Coming back to: Official shortage notices and what they authorise Replied, post #35 · Access › Shortages · 23 Feb 2025 · 29 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
SNAC and the mechanism of oral peptide absorption Replied, post #8 · Compounds › Oral incretins · 20 Feb 2025 · 24 likes On post #4 — agreed on the reasoning, with one qualification. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not…
-
A promotion I argued against, and why I lost Replied, post #104 · Documentation › Doc review · 20 Feb 2025 · 16 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #38 · Practice › Side effects · 30 Dec 2024 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
What changed in 2026, by region Replied, post #27 · Access › International · 17 Dec 2024 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #4 · Compounds › Semaglutide · 5 Dec 2024 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #10 · Practice › Dosing & titration · 22 Nov 2024 · 18 likes This follows post #7 rather than contradicting it. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature…
-
Time to steady state after a dose increase Replied, post #39 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 14 likes I read post #37 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Food noise reducing and the disorientation that can follow Replied, post #20 · Wellbeing › Mental health · 11 Oct 2024 · 17 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #52 · Clinical › Prescriber conversations · 6 Sep 2024 · 0 likes This follows post #49 rather than contradicting it. Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring…
-
Correlation in a self-tracked dataset: what it can support Replied, post #135 · Research Methods › Statistics · 25 Aug 2024 · 21 likes Coming back to post #133, because the follow-up matters more than the original answer. Confidence intervals: rather than a single point estimate, a range of plausible…
-
Chronic kidney disease and the FLOW result Replied, post #18 · Clinical › Comorbidities · 16 Aug 2024 · 0 likes PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #41 · Evidence › Journal club · 19 Jul 2024 · 2 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Journal club: FLOW and the renal composite, component by component Replied, post #22 · Evidence › Journal club · 10 Jul 2024 · 8 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…